Steroids

Steroids · ISSN (e) 1878-5867 · 37 papers in corpus
article 2026
doi:10.1016/j.steroids.2026.109827 ·PMID:42401307

Endometriosis is a chronic inflammatory disease characterised by ectopic endometrial tissue, progressive fibrosis and chronic pain, with a pathogenesis that goes beyond oestrogen dependence. The central question this review seeks to answer …

review 2025
doi:10.1016/j.steroids.2024.109529 ·PMID:39532224

The family of 17β-hydroxysteroid dehydrogenases (17β-HSDs) occupies a prominent place due to its number of isoforms, which carry out a bidirectional transformation (reduction of a steroid carbonyl to alcohol and oxidation of a steroid alcoh…

article 2023
doi:10.1016/j.steroids.2023.109284 ·PMID:37487815

Estradiol and progesterone are key regulators of the menstrual cycle. In the human endometrium, progesterone induces morphological changes required for blastocyst implantation. Dysregulated response to progesterone can lead to endometrial p…

2023
doi:10.1016/j.steroids.2023.109329 ·PMID:37884178

Progesterone and progestin agonists are potent steroid hormones. There are at least three major types of progesterone receptor (PR) families that interact with and respond to progesterone or progestin ligands. These receptors include ligand…

review 2023
doi:10.1016/j.steroids.2023.109249 ·PMID:37207843

Cytochrome P450 aromatase (AROM) and steroid sulfatase (STS) are the two key enzymes for the biosynthesis of estrogens in human, and maintenance of the critical balance between androgens and estrogens. Human AROM, an integral membrane prote…

2022
doi:10.1016/j.steroids.2022.108998 ·PMID:35271867

The glucocorticoid receptor (GR) regulates transcription of genes involved in multiple processes. Medroxyprogesterone acetate (MPA), widely used in the injectable contraceptive Depo-MPA (DMPA), has off-target effects via the GR, which may r…

review 2022
doi:10.1016/j.steroids.2022.109040 ·PMID:35526781

PGRMC is a non-classical receptor that mediates the non-genomic responses to progesterone and is distributed in different subcellular compartments. PGRMC belongs to the membrane-associated progesterone receptor (MAPR) family. Two PGRMC subt…

other 2021
doi:10.1016/j.steroids.2021.108856 ·PMID:33945801

17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) and steroid sulfatase (STS) are involved in the synthesis of the most potent estrogen in the human body, estradiol (E2). These enzymes are known to play a pivotal role in the progression of…

other 2018
doi:10.1016/j.steroids.2018.09.009 ·PMID:30273695

17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) is a promising therapeutic target known to play a pivotal role in the progression of estrogen-dependent diseases such as breast cancer, and endometriosis. This enzyme is responsible for the…

2018
doi:10.1016/j.steroids.2018.07.010 ·PMID:30086356

An effort with the goal of discovering single-dose, long-lasting (>6 months) injectable contraceptives began using levonorgestrel (LNG)-17-β esters linked to a sulfonamide function purposed as human carbonic anhydrase II (hCA 2) ligands. On…

2014
doi:10.1016/j.steroids.2014.06.012 ·PMID:24971815

Estrogen receptors alpha (ERα) and beta (ERβ) are nuclear transcription factors that are involved in the regulation of many complex physiological processes in humans. Modulation of these receptors by prospective therapeutic agents is curren…

2014
doi:10.1016/j.steroids.2014.07.013 ·PMID:25084324

Our understanding of the molecular mechanisms underlying the pharmacological actions of estrogen receptor (ER) ligands has evolved considerably in recent years. Much of this knowledge has come from a detailed dissection of the mechanism(s) …

2014
doi:10.1016/j.steroids.2013.10.012 ·PMID:24189185

Human aldo-keto reductases AKR1C1-AKR1C4 and AKR1D1 play essential roles in the metabolism of all steroid hormones, the biosynthesis of neurosteroids and bile acids, the metabolism of conjugated steroids, and synthetic therapeutic steroids.…

other 2013
doi:10.1016/j.steroids.2012.12.002 ·PMID:23276631

PGRMC2 (progesterone receptor membrane component 2) is highly homologous if compared with PGRMC1, a cytochrome-related protein, which is induced in several cancers and linked to cell growth in these cancers. Further it seems to be involved …

other 2013
doi:10.1016/j.steroids.2013.04.003 ·PMID:23607964

Progesterone receptor (PR) plays a key role in reproductive functions, and compounds that inhibit progesterone action (antiprogestins) have potential use in the treatment of estrogen- and progesterone-dependent diseases, including uterine l…

other 2013
doi:10.1016/j.steroids.2012.09.010 ·PMID:23178161

A series of antiprogestins have been synthesized by partially fluorinating the steroid molecule in positions relevant for receptor binding. By introducing fluorine at the exo-methylene of the 17 spirofuran ring, we obtained partial agonists…

2012
doi:10.1016/j.steroids.2012.02.003 ·PMID:22421057

The progesterone receptor (PR) plays a key role in reproduction and is important in cancers of the reproductive tract. Current PR antagonists usually compete for progestin binding in the PR ligand-binding pocket and often exhibit cross-bind…

other 2012
doi:10.1016/j.steroids.2012.03.013 ·PMID:22484153

Progesterone plays a central role in women's reproductive health. Synthetic progestins, such as medroxyprogesterone acetate (MPA) are often used in hormone replacement therapy (HRT), oral contraceptives, and for the treatment of endometrios…

review 2012
doi:10.1016/j.steroids.2011.10.013 ·PMID:22108547

Aromatase is expressed in multiple tissues, indicating a crucial role for locally produced oestrogens in the differentiation, regulation and normal function of several organs and processes. This review is an overview of the role of aromatas…

other 2011
doi:10.1016/j.steroids.2011.02.043 ·PMID:21376746

Dydrogesterone is widely used for menstrual disorders, endometriosis, threatened and habitual abortion and postmenopausal hormone replacement therapy. Although progestins have a promiscuous nature, dydrogesterone does not have clinically re…

article 2010
doi:10.1016/j.steroids.2010.08.010 ·PMID:20851710

Prostaglandin E(2) (PGE(2)) is a major mediator in the pathophysiology, and pathogenesis of gynecological diseases associated with abnormal endometrial disease with proliferation and inflammation, such as endometriosis. In this study, we in…

2010
doi:10.1016/j.steroids.2010.02.004 ·PMID:20156469

Steroid hormones participate in organ development, reproduction, body homeostasis, and stress responses. The steroid machinery is expressed in a development- and tissue-specific manner, with the expression of these factors being tightly reg…

article 2009
doi:10.1016/j.steroids.2009.07.011 ·PMID:19665469

Endometriosis, defined as the presence of endometrial glands and stroma at extra-uterine sites, is a gynecological condition that affects women of reproductive age. Consistent with its uterine origins, endometriotic lesions and resulting sy…

2008
doi:10.1016/j.steroids.2008.01.017 ·PMID:18321551

Estrogens are synthesized by the aromatase enzyme encoded by the Cyp19a1 gene, which contains an unusually large regulatory region. In most mammals, aromatase expression is under the control of two distinct promoters a gonad- and a brain-sp…

other 2006
doi:10.1016/j.steroids.2006.02.002 ·PMID:16597452

Progesterone receptor modulators have diverse potential therapeutic uses, including the treatment of endometriosis, uterine fibroids and breast cancer. Here we describe the molecular properties and preclinical pharmacology of a new steroida…